Endocrinology / diabetes clinical trials recruiting in Florida

406 recruiting endocrinology / diabetes trials match in Florida. Showing 20.

• ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid TumorsRecruiting

  Phase 1 / Phase 2 · Immatics US, Inc. · Miami, Florida

• MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid TumorsRecruiting

  Phase 1 · Memgen, Inc. · Tampa, Florida

• Infusion of Autologous T Cells Engineered to Target FSH Receptor in Recurrent Ovarian CancerRecruiting

  Phase 1 · H. Lee Moffitt Cancer Center and Research Institute · Tampa, Florida

• An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)Recruiting

  Phase 3 · AstraZeneca · Clearwater, Florida

• A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or TirzepatideRecruiting

  Phase 2 · Eli Lilly and Company · Ocala, Florida

• A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist UseRecruiting

  Phase 3 · Vanda Pharmaceuticals · Tampa, Florida

• A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or OverweightRecruiting

  Phase 2 · Eli Lilly and Company · Miami, Florida

• Comprehensive Outcomes for After Cancer HealthRecruiting

  N/A · Pack Health · Boston, Massachusetts

• Community Park-Based Programs for Health Promotion: Fit2Play Prospective Cohort StudyRecruiting

  N/A · Duke University · Miami, Florida

• A Study to Investigate APL-5125 in Adults With Advanced Solid TumorsRecruiting

  Phase 1 / Phase 2 · Apollo Therapeutics Ltd · Sarasota, Florida

• A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' DiseaseRecruiting

  Phase 2 · Immunovant Sciences GmbH · Doral, Florida

• A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly IncretinRecruiting

  Phase 3 · Eli Lilly and Company · Atlantis, Florida

• Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) MutationRecruiting

  Phase 1 · Senhwa Biosciences, Inc. · Tampa, Florida

• Study Evaluating Safety, Tolerability, and Metabolism of NiraparibRecruiting

  Phase 4 · University of Miami · Fort Lauderdale, Florida

• Bikini vs Longitudinal Incision in Direct Anterior Approach (DAA) Total Hip Arthroplasty (THA)Recruiting

  N/A · University of Miami · Miami, Florida

• Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)Recruiting

  N/A · Jaeb Center for Health Research · Aurora, Colorado

• Study of CP-383 in Patients With Advanced or Metastatic Solid TumorsRecruiting

  Phase 1 / Phase 2 · Tasca Therapeutics · Orlando, Florida

• Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)Recruiting

  Phase 3 · Genelux Corporation · Orlando, Florida

• AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce PainRecruiting

  Phase 3 · Novo Nordisk A/S · Jacksonville, Florida

• A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway AlterationsRecruiting

  Phase 1 / Phase 2 · Terremoto Biosciences Inc. · Orlando, Florida

Source: ClinicalTrials.gov. Recruitment status changes often — confirm on each study page.